Compare ARQT & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | MNDY |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.9B |
| IPO Year | 2020 | 2021 |
| Metric | ARQT | MNDY |
|---|---|---|
| Price | $24.88 | $84.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 26 |
| Target Price | $34.00 | ★ $167.65 |
| AVG Volume (30 Days) | ★ 1.6M | 1.2M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.85 | $20.70 |
| Revenue Next Year | $29.39 | $16.48 |
| P/E Ratio | $813.00 | ★ $34.38 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $16.62 | $57.50 |
| 52 Week High | $31.77 | $220.80 |
| Indicator | ARQT | MNDY |
|---|---|---|
| Relative Strength Index (RSI) | 47.67 | 43.04 |
| Support Level | $22.73 | $68.05 |
| Resistance Level | $25.25 | $87.95 |
| Average True Range (ATR) | 0.91 | 4.55 |
| MACD | -0.04 | -1.06 |
| Stochastic Oscillator | 42.09 | 3.03 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Monday.com Ltd is an artificial intelligence work platform that runs and orchestrates the core of all work. The platform democratizes access to software, including AI, enabling organizations to easily build applications and work management tools that fit their needs. The cloud-based platform is a no-code and low-code framework built from modular building blocks that are simple enough for anyone to use, yet powerful enough to drive core business across any organization. The platform also integrates with other systems and applications, creating a connective layer for organizations that links departments and bridges information silos. In addition to the core products, it introduced four core Al work capabilities: monday sidekick, monday vibe, monday agents, and workflows.